Mark Bloch (M Bloch)

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 4

Top Topics

Antiretroviral Therapy

Top Venues

HIV clinical trials

This page only lists publications with an associated author ORCID identifier.

Publications

Beng Eu, Joshua Dawe, Matthew Dunn, Kevin Lee, Norman Roth, Scott Griffiths, Mark Bloch, David Baker, Clara Soo, Fiona Bisshop, Mark Stoové
Are there additional adverse effects of testosterone use among men living with HIV?-Data from the PUSH! study. HIV medicine (2022)
Mark Bloch, M John, D Smith, T A Rasmussen, E Wright
Managing HIV-associated inflammation and ageing in the era of modern ART. HIV medicine (2021)
Htein Linn Aung, Mark Bloch, T Vincent, D Quan, A Jayewardene, Zhixin Liu, Thomas M Gates, Bruce J Brew, Limin Mao, Lucette A Cysique
Cognitive ageing is premature among a community sample of optimally treated people living with HIV. HIV medicine 22 (3) (2020)
Anton Pozniak, Jason Flamm, Andrea Antinori, Mark Bloch, Douglas Ward, Juan Berenguer, Pierre Côté, Kristen Andreatta, William Garner, Javier Szwarcberg, Thai Nguyen-Cleary, Damian J McColl, David Piontkowsky
Switching to the single-tablet regimen of elvitegravir, cobicistat, emtricitabine, and tenofovir DF from non-nucleoside reverse transcriptase inhibitor plus coformulated emtricitabine and tenofovir DF regimens: Week 96 results of STRATEGY-NNRTI. HIV clinical trials 18 (4) (2017)